Canada:
Supreme Court Denies Leave In Perindopril Accounting Of Profits Decision
04 November 2020
Smart & Biggar
To print this article, all you need is to be registered or login on Mondaq.com.
On September 24, 2020, the Supreme Court of Canada denied leave
to Apotex (Docket No. 39172) with respect to a decision affirming
the quantum of profits payable to the Plaintiffs ADIR and Servier
for infringement of
ADIR'S perindopril patent.
As
previously reported, the Federal Court of Appeal found that the
Federal Court made no palpable and overriding error in holding that
Apotex would not have used a non-infringing alternative from
third-party manufacturers.
The preceding is intended as a timely update on Canadian
intellectual property and technology law. The content is
informational only and does not constitute legal or professional
advice. To obtain such advice, please communicate with our offices
directly.
POPULAR ARTICLES ON: Litigation, Mediation & Arbitration from Canada
Can A Lawyer Challenge The Terms Of Their Own Retainer Agreement?
Lerners LLP
In Bimman v. Igor Ellyn Professional Corporation (Ellyn Law), the Court of Appeal for Ontario considered the circumstances in which a court may set aside a retainer agreement between a lawyer and their client on the basis that it is not fair and reasonable to the lawyer.
Maisonneuve: Right Of Way
McLeish Orlando LLP
Jessica Renee Salickram was on her way home after ending a shift at the Eaton Centre on January 7, 2018. She stepped off the bus at her stop, but her stop was 300 metres...